Host Hotels & Resorts HST

Reference table

1. What it is

Host Hotels & Resorts (NASDAQ: HST) is the world's largest lodging real estate investment trust — an owner (not an operator) of roughly 46,100 rooms across 74 hotels, mostly in the US plus five international sites, concentrated in the luxury and upper-upscale tiers. It holds the real estate and third-party brands run the hotels under management agreements: Marriott, Ritz-Carlton, Westin, Sheraton, W, St. Regis, Hyatt, Fairmont, Hilton and others. It also holds non-controlling stakes in seven joint ventures. The company is tiny in headcount (165 employees) because operations are outsourced to the brands; Host is essentially a capital-allocation and asset-management vehicle. CEO James F. Risoleo; Bethesda, MD; fiscal year ends December 31.

Revenue mix (FY2025, from filings):

• By type (product segmentation): Occupancy (rooms) $3.61B (59%) · Food & Beverage $1.80B (29%) · Other hotel $0.60B (10%). A pure lodging revenue stream — no diversification into other property types.
• By geography: United States $6.01B (~98%) · non-US $0.10B (~2%). Within the US, the biggest markets are New York City ($516M), Orlando ($504M), San Diego ($494M), Florida Gulf Coast ($451M), San Francisco/San Jose ($397M) and Phoenix ($371M). Essentially a US luxury-lodging concentration — a sun-belt/leisure and gateway-city bet.

The business model has no organic unit-growth engine: Host grows by acquiring hotels, renovating/repositioning them (ROI capex), and riding RevPAR (revenue per available room), while recycling capital out of lower-growth assets. In FY2026 it sold the Four Seasons Orlando, Four Seasons Jackson Hole and St. Regis Houston for ~$1.15B combined (§9).

2. The expert thesis — why the panel is bullish (traceable)

There is no expert coverage of HST in the Synthos knowledge base. total_claims = 0, breadth = 0, net conviction = 0. No net-bullish voices, no cautionary voice, no traceable claim_ids.

Per the Synthos house standard, we do not fabricate conviction. This verdict is therefore entirely fundamentals- and quant-driven: the scores, the Bull/Base/Bear model, and the Watch call below rest on the reported financials, the live analyst estimates (FMP), the price-target consensus, and management's own SEC-filed guidance — nothing else. Where the LLY-style note would cite a panel of investors, here we have only the numbers, and we weight them accordingly (low conviction, wide honest range). If HST later attracts expert coverage, this section and the conviction rating will be revised.

For external context only (not Synthos conviction): the sell-side is mildly positive — 23 Buy, 18 Hold, 2 Sell, consensus "Buy" — and FMP's letter rating is A (overall score 4/5), dragged only by debt-to-equity (2/5) and price-to-book (2/5) sub-scores. Treat those as third-party context, not our thesis.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them. Because HST is best valued on cash flow, we anchor on P/AFFO (adjusted funds from operations, the REIT earnings measure) with a cross-check on EV/EBITDA.

Synthos fair value = the base case, ~$23 (roughly flat to spot), with the full $17–$29 span as the honest range. This sits essentially on top of the Street's $23.81 consensus and $23 median — we see no valuation edge in either direction. This is a tracked call — the Forecaster Scorecard grades it once it matures. The absence of a mispricing, combined with the absence of a growth catalyst, is exactly why the verdict is Watch rather than Buy.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). HST is neither an exponential nor even a fast compounder — it is a mature, cyclical income vehicle:

• Forward growth: revenue is essentially flat on consensus — FY25 $6.11B → FY26E $6.12B → FY27E $6.13B → FY28E $6.34B (a ~1% CAGR). GAAP EPS is forecast to decline from an asset-sale-inflated FY26E $1.29 toward ~$0.96 by FY28E. There is no earnings-growth engine in the estimates.
• Acceleration (2nd derivative) is flat-to-negative: the post-COVID RevPAR recovery is over. Revenue growth decelerated from the recovery surge (FY21 +78%, FY22 +70%, FY23 +8%) to a mature ~4–8%, and the estimates say it flattens from here. Per our flagship philosophy we hunt forward next-exponentials with positive acceleration and room to run — HST has neither.
• Room to run: the lodging market is a fixed-size, GDP-linked TAM. Host grows share only by acquiring hotels (using shareholder capital) — there is no software-style operating leverage or platform expansion. A ~$16B cap in a mature category caps the multibagger structurally.
• Reinvestment runway: capex is heavy and maintenance-like (renovations, ROI repositioning at ~$0.64B/yr) rather than growth-generative; capex-to-depreciation ~0.79× means it is largely sustaining the existing box.

Exponential Potential: Very Low (2/10). Own HST — if at all — for the yield and cyclical exposure, never for compounding or a multibagger. This honest framing is why HST cannot sit in a growth or flagship sleeve.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY25 $6.11B, +7.6% (FY24 $5.68B, +7.0% on FY23 $5.31B). Solidly past the pandemic trough (FY20 $1.62B) and above the 2019 pre-COVID base (~$5.5B), but the recovery tailwind is spent.
• Quarterly trajectory: Q1'25 $1.59B → Q2 $1.59B → Q3 $1.33B (seasonal) → Q4 $1.60B → Q1'26 $1.65B (+3.2% YoY). Seasonal, low-single-digit organic growth — no acceleration.
• Margins: EBITDA margin 34.3% TTM, net margin 16.4% TTM. Q1'26 GAAP operating margin 19.4% (per the release, +150 bps YoY). These are healthy for lodging but move with occupancy.
• Earnings & FFO: FY25 net income $765M, EPS $1.10. The REIT-relevant number is FFO: Q1'26 NAREIT FFO/diluted share $0.66 and Adjusted FFO/share $0.67 (+4.7% YoY, per the SEC release). Q1'26 GAAP EPS spiked to $0.71–0.72 on the Four Seasons sale gain — a non-recurring boost.
• Cash flow: operating CF $1.50B FY25, capex −$0.64B, FCF $0.86B. FCF comfortably covers the ~$0.62B regular dividend but not the special dividends, which are funded by asset sales.
• Balance sheet: total debt $5.64B, cash $0.77B, net debt $4.87B. Net-debt/EBITDA ~1.9× TTM (management cites a low-leverage, investment-grade profile; weighted-avg maturity 4.9 yrs at 4.8%, no 2026 maturities, ~$3.4B liquidity). This is the genuine strength of the story — a fortress balance sheet for a cyclical.

6. Valuation — priced in or room?

HST is fairly valued, not cheap and not expensive. Trailing P/E is 16×, but P/E is the wrong lens for a REIT — on cash flow it trades ~9× P/AFFO (AFFO/share ~$2.60) and 9.4× EV/EBITDA TTM, both roughly mid-cycle for a high-quality lodging REIT. P/B 2.4× and EV/sales 3.2× are unremarkable. The dividend is the draw: TTM payout $1.67 = ~7.2% yield, but that includes a $0.72 special dividend from the Four Seasons sale — the recurring regular dividend is $0.20/quarter = $0.80/yr, a ~3.4% base yield, with specials layered on as asset sales occur. FCF covers the regular dividend (payout ~65% of FCF); specials are self-funding from dispositions.

Reverse read: at ~9× P/AFFO the market is pricing a normal, no-recession lodging cycle with low-single-digit RevPAR — neither boom nor bust. That is a reasonable base case, which is precisely why there is little valuation edge. Street targets (context): consensus $23.81, high $27, low $18, median $23 — our ~$23 base FV sits right in the middle. Not a value buy, not a short; a fairly-priced cyclical income holding.

7. Technicals (from the tech block)

• Trend: mildly up. $23.35 sits above the 50-DMA ($22.97) and 200-DMA ($19.45), with the 50 above the 200 (constructive posture). MACD +0.27 (mildly positive).
• Location: −7.1% off the 52-week high ($25.13) and +52.9% off the 52-week low ($15.27) — well off the lows after a strong 12 months, modest drawdown from peak (max −7.1%).
• Momentum: RSI(14) 38 — weak/soft, near the lower half of the range and approaching oversold (<30). No overbought risk; if anything, near-term momentum has cooled.
• Relative strength: HST +47.1% 12-mo vs SPY +20.6% and QQQ +30.3%; +22.3% 3-mo vs SPY +13.7% / QQQ +22.0%. It has meaningfully outperformed the market over the past year — a mean-reversion/recovery re-rate that is now largely complete.
• Read: technicals are neutral-to-mildly-constructive — an intact uptrend, but soft RSI and a stock that has already run hard off its lows. No urgency either way; consistent with a Watch.

8. Moat & competitive position

Host's "moat" is scale and asset quality, not a durable competitive barrier. As the largest lodging REIT it has (1) the best-located, highest-quality luxury/upper-upscale portfolio in gateway and resort markets; (2) an investment-grade balance sheet that lets it buy when weaker owners are forced sellers (a real cyclical advantage); and (3) brand relationships with Marriott/Hyatt/Hilton that outsource operating risk. But the underlying business — owning hotels — has no pricing-power moat: RevPAR is set by supply/demand and the macro cycle, brands (not Host) own the customer, and the assets are capital-hungry. It is a well-run taker of the lodging cycle, not a shaper of it.

Peer set (FMP-supplied REITs, market cap): Gaming & Leisure Properties $12.4B, Omega Healthcare $14.7B, Lamar Advertising $16.0B, Equity LifeStyle $12.8B, Camden Property Trust $11.8B, UDR $13.4B, American Homes 4 Rent $12.2B, BXP $11.1B, AGNC $12.6B, Rexford Industrial $7.9B. Note these are FMP's REIT comps by size, not direct lodging competitors — the true peers are Park Hotels, Pebblebrook, RLJ and Ryman among lodging REITs, plus the brand operators (Marriott, Hilton) as an asset-light contrast. Within the group HST is the largest and among the best-balance-sheet names, which justifies a modest quality premium but not a growth multiple.

9. Management, capital allocation & guidance

• Capital allocation: disciplined and shareholder-friendly for a cyclical REIT. In Q1'26 Host sold three hotels for ~$1.15B (Four Seasons Orlando & Jackson Hole for $1.1B; St. Regis Houston for $51M), shedding assets with heavy pending capex needs, and returned the ~$500M taxable gain via a $0.72 special dividend. It also repurchased 4.0M shares at ~$18.97 in Q1'26 ($75M; $405M capacity remaining) — buying below the current price. Regular dividend $0.20/quarter. This is textbook REIT capital recycling.
• Insider activity: the sampled window (May 2026) shows routine director equity awards (deferred stock units) and two small officer/director sales (EVP/CIO Tyrrell 15,569 sh at $23; director Rakowich 3,408 sh at ~$22.90) — normal, immaterial, no alarming cluster.
• Management's own guidance (half-weighted — their own book): in the 2026-05-06 SEC 8-K / Q1'26 earnings release, management raised full-year 2026 guidance: comparable-hotel RevPAR growth to 3.0%–4.5% (from prior) and comparable-hotel Total RevPAR growth to 3.5%–5.0% over 2025. CEO Risoleo cited "strong leisure demand… affluent consumers continuing to prioritize spending on travel, and group demand remains steady." Q1'26 delivered comparable RevPAR +4.4% and Adjusted EBITDAre +5.6%. Treat this as management's self-interested framing (half-weight), but it is a real, specific, raised guide and corroborates the low-single-digit-growth base case — not a growth acceleration.

10. Catalysts & what to watch

• Next earnings: 2026-08-05 (Q2'26; Street EPS $0.33, revenue ~$1.61B). The key line: comparable RevPAR and Total RevPAR vs the raised 3.0–4.5% / 3.5–5.0% guide, and any further guidance revision.
• Group vs transient mix: group demand (34% of room sales) holding up is the tell that corporate/convention travel is intact; transient (61%) tracks the consumer.
• Capital recycling: further dispositions/acquisitions and buyback pace (below-NAV repurchases are accretive).
• Special dividends: additional asset sales could fund more specials — good for total yield, but not recurring income.
• Macro: lodging is a leading recession casualty — watch consumer spending, corporate travel budgets, and any RevPAR deceleration or turn negative.

Thesis tripwires (what would change the call): two consecutive quarters of negative comparable RevPAR (bear trigger); a regular-dividend cut (structural warning); leverage rising materially above ~3× net-debt/EBITDA; or a de-rating below ~7.5× P/AFFO that opens a genuine valuation edge (would move it toward Buy — Tactical).

11. Key risks

• Cyclicality (structural, the big one): lodging RevPAR is among the most economically sensitive of all real estate; a recession compresses earnings and can force a dividend cut. Beta 1.13 understates the operating leverage.
• No growth catalyst: flat-to-down forward earnings estimates mean the stock relies on multiple stability and yield — there is no earnings tailwind to bail out a valuation stumble.
• Capital intensity: hotels require continuous heavy renovation capex; ROI capex must clear its hurdle or it destroys value.
• US/luxury concentration: ~98% US revenue and a luxury/upper-upscale skew ties results to the affluent US consumer and gateway/resort markets.
• Interest-rate & leverage sensitivity: as a levered REIT, rising rates pressure both cap-rate-driven asset values and refinancing costs (though no 2026 maturities and a 4.8% weighted rate cushion the near term).
• Dividend optics: the headline ~7% yield is flattered by non-recurring special dividends; the recurring base yield is ~3.4%.
• No expert coverage: with 0 KB claims, there is no independent conviction layer — the call rests solely on fundamentals and quant, which we reflect as Low conviction.

12. Verdict, position sizing & monitoring

Watch. Host is a well-run, investment-grade, largest-in-class lodging REIT trading at a fair price with no growth catalyst. The balance sheet is a genuine strength, the capital allocation (dispositions, buybacks below price, disciplined dividend) is shareholder-friendly, and management just raised guidance — but forward estimates are flat-to-down, the business is deeply cyclical, our base-case fair value (~$23) sits right on the Street's target and the current price, and there is no expert conviction in the KB to tip the scales. There is no mispricing to exploit and no growth to compound. That combination is the textbook definition of Watch: nothing broken, nothing compelling.

• Sizing: if owned at all, income/satellite only, 0–2% — a yield-and-cyclical-exposure sleeve holding, never a core or flagship position. A better entry would be a cyclical dislocation (bear-case ~$17 / sub-8× P/AFFO), which would flip this toward Buy — Tactical.
• Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, watching comparable RevPAR vs the guided band and the regular dividend's coverage. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $23.35.
• Single biggest risk: a consumer/travel downturn that collapses RevPAR and pressures the dividend — the defining vulnerability of any lodging REIT.

Provenance & disclosures

• Traceability: 0 KB claims, breadth 0 — HST has no expert coverage in the Synthos knowledge base, so no claim_ids are cited and the verdict is explicitly fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation); here that means we assert no conviction beyond the numbers.
• Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-05-06 SEC 8-K (Q1'26 earnings release). Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
• Management caveat: management's raised FY26 RevPAR guidance is management's own book, half-weighted by design; it corroborates but does not drive the call.
• Note on figures: GAAP Q1'26 EPS was inflated by a non-recurring Four Seasons sale gain; the recurring measure is AFFO/share (~$0.67 Q1'26). TTM EV/EBITDA and net-debt/EBITDA use FMP's TTM EBITDA, which is elevated by that same gain — clean FY25 leverage is modestly higher (~2.6× on FY25 EBITDA) but still investment-grade.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").